Gilde Healthcare is a specialized healthcare investor with two primary fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund targets innovative healthtech and therapeutics companies in Europe and North America, while the Private Equity fund focuses on profitable European lower mid-market healthcare providers, suppliers, and service providers. Their overarching investment philosophy is to support businesses that enable better care at lower cost.
Portfolio
3
Fund Size
$2.6B
Top Stage
Series B
Last 12 Mo
1
Team
ED
Edwin de Graaf
Founder and Managing Partner
JD
Janke Dittmer
Partner
AM
Arnaud Marie
General Manager for Global Interventional
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| ProVerum Limited | Series B | $80M | Aug 2025 |
| Purespring Therapeutics | Series B | $105M | Oct 2024 |
| Karius | Series D | $100M | May 2024 |
Top Co-Investors
Khosla Ventures1 shared
Sofinnova Partners1 shared
Forbion1 shared
British Patient Capital1 shared
OrbiMed1 shared
Lightstone Ventures1 shared
Atlantic Bridge1 shared
Enterprise Ireland1 shared
Last updated: 1 March 2026